What's new? Log in Free sign up

Assertio (ASRT) News and press releases

Company Profile

News

From Benzinga Pro

Lake Street Maintains Buy on Assertio Holdings, Raises Price Target to $9

News, Price Target, Analyst Ratings

Lake Street analyst Thomas Flaten maintains Assertio Holdings (NASDAQ:ASRT) with a Buy and raises the price target from $8 to $9.

BWS Financial Maintains Buy on Assertio Holdings, Raises Price Target to $10

News, Price Target, Analyst Ratings

BWS Financial analyst Hamed Khorsand maintains Assertio Holdings (NASDAQ:ASRT) with a Buy and raises the price target from $8 to $10.

Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.

McKesson, ICU Medical, Novavax And Other Big Stocks Moving Higher On Tuesday

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

U.S. stocks traded lower, with the Dow Jones dropping around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.

Recap: Assertio Holdings Q1 Earnings

Assertio Holdings (NASDAQ:ASRT) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:15 AM. Here's what investors need to know about the announcement. Earnings Assertio Holdings beat estimated earnings by 123.08%, reporting an EPS of $0.29 versus an estimate of $0.13.

Assertio Holdings Q1 EPS $0.29 Beats $0.13 Estimate, Sales $42.47M Beat $37.64M Estimate

Earnings, Earnings Beats, News

Assertio Holdings (NASDAQ:ASRT) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.13 by 123.08 percent. This is a 23.68 percent decrease over earnings of $0.38 per share from

Earnings Scheduled For May 9, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.

5 Value Stocks In The Healthcare Sector

Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

12 Health Care Stocks Moving In Tuesday's Intraday Session

Assertio Scoops Up Spectrum Pharma In $248M Stock Deal

Biotech, M&A, News, Penny Stocks, Health Care, Movers, General

Assertio Holdings Inc (NASDAQ: ASRT) will acquire Spectrum Pharmaceuticals Inc (NASDAQ: SPPI) in an all-stock and contingent value rights (CVR) transaction.

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

5 Value Stocks In The Healthcare Sector

Stocks React To February Jobs Report: The Winners And Losers

Large Cap, Mid Cap, News, Penny Stocks, Top Stories, Markets, Movers, Trading Ideas

The markets have offered investors a rollercoaster ride this week, with a flurry of activity and developments that have sent shockwaves through various sectors.

Assertio Therapeutics's Return On Capital Employed Overview

Why Assertio Therapeutics Shares Are Trading Higher Today

Small Cap, Movers

Assertio Therapeutics (NASDAQ: ASRT) shares are trading higher on Thursday after the company reported better-than-expected Q4 sales results.

Why JD.com Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

12 Health Care Stocks Moving In Thursday's Intraday Session

General Electric, Build-A-Bear Workshop, Asana And Other Big Stocks Moving Higher On Thursday

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Thursday. Here are some big stocks recording gains in today’s session.

Earnings Scheduled For March 8, 2023

Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.

Press releases

From Benzinga Pro

Assertio Reports First Quarter 2023 Financial Results, Raises Full Year 2023 Outlook

Earnings, Press Releases

Net Product Sales Increase 18% Year-Over-Year Raises Full Year Outlook to Net Product Sales of $157 to $167 Million, Adjusted EBITDA $90 to $98 Million To Acquire Spectrum Pharmaceuticals in All Stock

Assertio Holdings, Inc. Updates First Quarter 2023 Financial Results Call Time to Tuesday, May 9, 2023 at 11:30 am Eastern Time

News, Press Releases

LAKE FOREST, Ill., May 05, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (NASDAQ:ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ISEE, MDWT, ASRT

News, Legal, Press Releases

NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary

SHAREHOLDER ALERT: Weiss Law Reminds SPPI, NATI, CCFN, and ARST Shareholders About Its Ongoing Investigations

Small Cap, Press Releases

NEW YORK, May 1, 2023 /PRNewswire/ -- If you own shares in any of the companies listed above and would

Lifshitz Law PLLC Announces Investigations of HOTH, ASRT, SPPI, and CEI

News, Legal, Press Releases

NEW YORK, April 29, 2023 (GLOBE NEWSWIRE) -- Hoth Therapeutics, Inc. (NASDAQ:HOTH) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of HOTH with

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHBI, CBIO, TA, ASRT

NEW YORK, April 28, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties

SHAREHOLDER ALERT: Weiss Law Investigates Spectrum Pharmaceuticals, Inc.

NEW YORK, April 27, 2023 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Spectrum Pharmaceuticals, Inc. ("Spectrum

SHAREHOLDER ALERT: Weiss Law Investigates Assertio Holdings, Inc.

NEW YORK, April 27, 2023 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Assertio Holdings, Inc. ("Assertio" or the

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Spectrum Pharmaceuticals, Inc.

NEW YORK, April 25, 2023 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) and its board of directors concerning the proposed acquisition

ASRT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Assertio Holdings, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Assertio Holdings, Inc. (NASDAQ:ASRT) and Spectrum Pharmaceuticals, Inc. is fair to Assertio shareholders. Halper Sadeh encourages

Assertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc. in All Stock and CVR Transaction

M&A, News, Press Releases

Complementary Commercial Growth Platforms Anticipated to Accelerate ROLVEDON™ (eflapegrastim-xnst) Injection Profitability and Diversify Revenue Streams Combination of Assertio's Omni-Channel Digital Sales

Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

LAKE FOREST, Ill., April 07, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (NASDAQ:ASRT), a specialty pharmaceutical company offering differentiated products to patients, announced that

Assertio Reports Fourth Quarter and Full Year 2022 Financial Results

Earnings, Press Releases

Net Product Sales Increase 55% in the Fourth Quarter, 42% for the Full Year Full Year Net Income Increases to $109.6 Million, Non-GAAP Adjusted EBITDA Increases to $101.6 Million Cash Flows from Operations Was $26.7

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.